Helicobacter pylori sensitizes TNF-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP

Cell Death and Disease

Volumn 5, Issue 3, 2014, Pages

  Lin, W C ^a   Tsai, H F ^b,c   Liao, H J ^a   Tang, C H ^a   Wu, Y Y ^d   Hsu, P I ^e   Cheng, A L ^f   Hsu, P N ^a,f  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis signaling; DISC; FLIP; Helicobacter pylori; TRAIL

Indexed keywords

CASPASE 8; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; FLICE INHIBITORY PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; MODULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REGULATORY MECHANISM; SENSITIZATION; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM; STOMACH INJURY;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CELL LINE, TUMOR; CYTOCHROMES C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EPITHELIAL CELLS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MITOCHONDRIA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STOMACH; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84897371331     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.81     Document Type: Article

References (48)

1. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151: 1685-1703.
2. Moss SF, Calam J, Agarwal B, Wang S, Holt PG. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
3. Rudi J, Kuck D, Strand S, Von Herbay A, Mariani SM, Krammer PH et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest 1998; 102: 1506-1514.
4. Bamford KB, Fan XJ, Crowe SE, Leary JF, Gourley WK, Luthra GK et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998; 114: 482-492.
5. Elios MM, Manghetti M, De Carli M, Costa F, Baldari CT, Burroni D et al. T helper 1 effector cells specific for Helicobacter pylori in gastric antrum of patients with peptic ulcer disease. J Immunol 1997; 158: 962-967.
6. Wu YY, Tsai HF, Lin WC, Hsu PI, Shun CT, Wu MS et al. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis. Infect Immun 2007; 75: 4357-4363.
7. Tsai HF, Hsu PN. Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathology. Cell Mol Immunol 2010; 7: 255-259.
8. Wagner S, Beil W, Westermann J, Logan RPH, Bock CT, Trautwein C et al. Regulation of epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 1997; 113: 1836-1847.
9. Jones N, Day A, Jennings HA, Sherman PM. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 1999; 67: 4237-4242.
10. Wang J, Fan X, Lindholm C, Bennett M, O'Connoll J, Shanahan F et al. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/ Fas ligand interactions. Infect Immun 2000; 68: 4303-4311.
11. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-682.
12. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998; 161: 2833-2840.
13. Thomas WD, Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol 1998; 161: 2195-2200.
14. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J Exp Med 1999; 189: 1451-1460.
15. Kaplan MJ, Ray D, Mo RR, Yung RL, Richardson BC. TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages. J Immunol 2000; 164: 2897-2904.
16. Walczak H, Sprick MR. Biochemistry and function of the DISC. Trends Biochem Sci 2001; 26: 452-453.
17. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000; 12: 599-609.
18. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. Apo2L/ TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12: 611-620.
19. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2000; 2: 241-243.
20. Sprick MR, Rieser E, Stahl H, Grosse-Wilde A, Weigand M A, Walczak H. Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but cannot functionally substitute caspase-8. EMBO J 2002; 21: 4520-4530.
21. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001; 276: 46639-46646.
22. Wu YY, Tsai HF, Lin WC, Chou AH, Chen HT, Yang JC et al. Helicobacter pylori enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in human gastric epithelial cells. World J Gastroenterol 2004; 10: 2334-2339.
23. Chou AH, Tsai HF, Wu YY, Hu CY, Hwang LH, Hsu PI et al. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J Immunol 2005; 174: 2160-2166.
24. Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK, Huang HJ. Anticancer agents sensitize tumor cells to tumor necrosis factorrelated apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res 2000; 61: 1645-1651.
25. Wen J, Ramadevi N, Nguyen D, Perkins C, Worthington E, Bhalla K. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. Blood 2000; 96: 3900-3906.
26. Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H et al. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene 2001; 20: 2190-2196.
27. Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC et al. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ 2004; 11: S86-S96.
28. Reers M, Smith TW, Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescence indicator of membrane potential. Biochemistry 1991; 30: 448860-448844.
29. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA 1991; 88: 3671-3675.
30. Oishi M, Iizumi Y, Taniguchi T, Goi W, Miki T, Sakai T. Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2. PLoS One 2013; 8: e55922.
31. Abou El, Naga RN, Azab SS, El-Demerdash E, Shaarawy S, El-Merzabani M, Ammar ES. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals. Life Sci 2013; 92: 555-561.
32. Wang G, Wang X, Yu H, Wei S, Williams N, Holmes DL et al. Small-molecule activation of the TRAIL receptor DR5 in human cancer cells. Nat Chem Biol 2013; 9: 84-89.
33. Kim EY, Yu JS, YangM, Kim AK. Sub-toxic dose of apigenin sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5. Mol Cells 2013; 35: 32-40.
34. Surget S, Chiron D, Gomez-Bougie P, Descamps G, Ménoret E, Bataille R et al. Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells. Cancer Res 2012; 72: 4562-4573.
35. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-195.
36. Golk A, Brenner D, Fritsch C, Krammer PH, Lavrik IN. c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem 2005; 280: 14507-14513.
37. Scaffidi C, Schmitz I, Krammer PH, Peter ME. The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 1999; 274: 1541-1548.
38. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. Cellular flice-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 2001; 276: 20633-20640.
39. Karttunen R, Karttunen T, Ekre H-P T, MacDonald TT. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995; 36: 341-345.
40. Lindholm C, Quiding-Jalrbrink M, Lonroth H, Hamlet A, Svennerholm A-M. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 5964-5971.
41. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 2001; 167: 1347-1352.
42. Tsai HF, Lai JJ, Chou A, Wang TF, Wu CS, Hsu PN. Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 629-639.
43. Huang S, Tsai H, Tzeng H, Liao H, Hsu P. Lipid raft assembly and Lck recruitment in TRAIL costimulation mediates NF-kB activation and T cell proliferation. J Immunol 2011; 186: 931-939.
44. Gao LY, Kwaik YA. The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol 2000; 8: 306-313.
45. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-1501.
46. Asahi BM, Azuma T, Ito S, Ito Y, Suto H, Nagai Y et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593-602.
47. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-1268.
48. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA. Science 2002; 295: 683-686.